Metabolic Effects of Honey in Type 1 Diabetes Mellitus: A Randomized Crossover Pilot Study
Publication: Journal of Medicinal Food
Volume 16, Issue Number 1
Abstract
The aim of this study was to evaluate the metabolic effects of 12-week honey consumption on patients suffering from type 1 diabetes mellitus (DM). This was a randomized crossover clinical trial done in the National Institute for Diabetes and Endocrinology, Cairo, Egypt. Twenty patients of both sexes aged 4–18 years with type 1 DM and HbA1C<10% participated in the study. They were randomized into two equal groups (intervention to control and control to intervention). The dietary intervention was 12-week honey consumption in a dose of 0.5 mL/kg body weight per day. The main outcome measures were serum glucose, lipids, and C-peptide, and anthropometric measurements. None of participants were lost in follow-up. The intervention resulted in significant decreases in subscapular skin fold thickness (SSFT; P=.002), fasting serum glucose (FSG; P=.001), total cholesterol (P=.0001), serum triglycerides (TG; P=.0001), and low-density lipoprotein (P=.0009), and significant increases in fasting C-peptide (FCP; P=.0004) and 2-h postprandial C-peptide (PCP; P=.002). As possible long-term effects of honey after its withdrawal, statistically significant reductions in midarm circumference (P=.000), triceps skin fold thickness (P=.006), SSFT (P=.003), FSG (P=.005), 2-h postprandial serum glucose (P=.000), TG (P=.003), and HbA1C (P=.043), and significant increases in FCP (P=.002) and PCP (P=.003) were observed. This small clinical trial suggests that long-term consumption of honey might have positive effects on the metabolic derangements of type 1 DM.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Buschard K. What causes type 1 diabetes? Lessons from animal modelsAPMIS2011119Suppl 1321-19. 1. Buschard K: What causes type 1 diabetes? Lessons from animal models. APMIS 2011;119(Suppl 132):1–19.
2.
EURODIAB ACE Study Group: Variation and trends in incidence of childhood diabetes in EuropeLancet2000355873-876. 2. EURODIAB ACE Study Group: Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000;355:873–876.
3.
Bogdanov SJurendic TSieber RGallmann P. Honey for nutrition and health: a reviewJ Am Coll Nutr200827677-689. 3. Bogdanov S, Jurendic T, Sieber R, Gallmann P: Honey for nutrition and health: a review. J Am Coll Nutr 2008;27:677–689.
4.
White J. Composition of honeyHoney: A Comprehensive SurveyCrane EHeinemann EditionLondon1975157-206. 4. White J: Composition of honey. In: Honey: A Comprehensive Survey (Crane E, ed.), Heinemann Edition, London, 1975, pp. 157–206.
5.
Abdulrhman MEl-Hefnawy MHussein REl-Goud AA. The glycemic and peak incremental indices of honey, sucrose and glucose in patients with type 1 diabetes mellitus: effects on C-peptide level-a pilot studyActa Diabetol20114889-94. 5. Abdulrhman M, El-Hefnawy M, Hussein R, El-Goud AA: The glycemic and peak incremental indices of honey, sucrose and glucose in patients with type 1 diabetes mellitus: effects on C-peptide level-a pilot study. Acta Diabetol 2011;48:89–94.
6.
Agrawal OPPachauri AYadav HUrmila JGoswamy HMChapperwal A et al. Subjects with impaired glucose tolerance exhibit a high degree of tolerance to honeyJ Med Food200710473-478. 6. Agrawal OP, Pachauri A, Yadav H, Urmila J, Goswamy HM, Chapperwal A, et al.: Subjects with impaired glucose tolerance exhibit a high degree of tolerance to honey. J Med Food 2007;10:473–478.
7.
Al Waili NS. Natural honey lowers plasma glucose, Creactive protein, homocysteine, and blood lipids in healthy, diabetic, and hyperlipidemic subjects: comparison with dextrose and sucroseJ Med Food20047100-107. 7. Al Waili NS: Natural honey lowers plasma glucose, Creactive protein, homocysteine, and blood lipids in healthy, diabetic, and hyperlipidemic subjects: comparison with dextrose and sucrose. J Med Food 2004;7:100–107.
8.
Ionescu-Tirgoviste CPopa ESintu EMihalache NCheta DMincu I. Blood glucose and plasma insulin responses to various carbohydrates in type 2 non-insulin-dependent diabetesDiabetologia19832480-84. 8. Ionescu-Tirgoviste C, Popa E, Sintu E, Mihalache N, Cheta D, Mincu I: Blood glucose and plasma insulin responses to various carbohydrates in type 2 non-insulin-dependent diabetes. Diabetologia 1983;24:80–84.
9.
Samanta ABurden ACJones GR. Plasma glucose responses to glucose, sucrose, and honey in patients with diabetes mellitus: an analysis of glycemic and peak incremental indicesDiabet Med19852371-373. 9. Samanta A, Burden AC, Jones GR: Plasma glucose responses to glucose, sucrose, and honey in patients with diabetes mellitus: an analysis of glycemic and peak incremental indices. Diabet Med 1985;2:371–373.
10.
Shambaugh PWorthington VHerbert JH. Differential effects of honey, sucrose, and fructose on blood sugar levelsJ Manip Physiol Ther199013322-325. 10. Shambaugh P, Worthington V, Herbert JH: Differential effects of honey, sucrose, and fructose on blood sugar levels. J Manip Physiol Ther 1990;13:322–325.
11.
Bahrami MAtaie-Jafari AHosseini SForuzanfar MHRahmani MPajouhi M. Effects of natural honey consumption in diabetic patients: an 8-week randomized clinical trialInt J Food Sci Nutr200960618-626Abstract. 11. Bahrami M, Ataie-Jafari A, Hosseini S, Foruzanfar MH, Rahmani M, Pajouhi M: Effects of natural honey consumption in diabetic patients: an 8-week randomized clinical trial. Int J Food Sci Nutr 2009;60:618–626. Abstract.
12.
Oizumi TDaimon MJimbu YKameda WArawaka NYamaguchi H et al. A palatinose based formula improves glucose tolerance, serum free fatty acid levels and body fat compositionTohoku J Exp Med200721291-99. 12. Oizumi T, Daimon M, Jimbu Y, Kameda W, Arawaka N, Yamaguchi H, et al.: A palatinose based formula improves glucose tolerance, serum free fatty acid levels and body fat composition. Tohoku J Exp Med 2007;212:91–99.
13.
Dahlquist AAuricchio SSemenza GPrader A. Human intestinal disaccharidases and hereditary disaccharide intolerance: the hydrolysis of sucrose, isomaltose, palatinose (isomaltulose), and 1, 6-a-oligosaccharide (isomalto-oligosaccharide) preparationJ Clin Invest196342556-562. 13. Dahlquist A, Auricchio S, Semenza G, Prader A: Human intestinal disaccharidases and hereditary disaccharide intolerance: the hydrolysis of sucrose, isomaltose, palatinose (isomaltulose), and 1, 6-a-oligosaccharide (isomalto-oligosaccharide) preparation. J Clin Invest 1963;42:556–562.
14.
Lina BAJonker DKozianowski G. Isomaltulose (palatinose): a review of biological and toxicological studiesFood Chem Toxicol2002401375-1381. 14. Lina BA, Jonker D, Kozianowski G: Isomaltulose (palatinose): a review of biological and toxicological studies. Food Chem Toxicol 2002;40:1375–1381.
15.
Berger BStenström GSundkvist G. Random C-peptide in the classification of diabetesScand J Clin Lab Invest200060687-693. 15. Berger B, Stenström G, Sundkvist G: Random C-peptide in the classification of diabetes. Scand J Clin Lab Invest 2000;60:687–693.
16.
Crane EA Book of HoneyOxford University PressOxford, United Kingdom1980198. 16. Crane E: A Book of Honey. Oxford University Press, Oxford, United Kingdom, 1980, p. 198.
17.
Gharib NMRasheed P. Anthropometry and body composition of school children in BahrainAnn Saudi Med200929258-269. 17. Gharib NM, Rasheed P: Anthropometry and body composition of school children in Bahrain. Ann Saudi Med 2009;29:258–269.
18.
Kaye FPHolt SJanette C. International table of glycemic index and glycaemic load valuesAm J Clin Nutr2002765n56. 18. Kaye FP, Holt S, Janette C: International table of glycemic index and glycaemic load values. Am J Clin Nutr 2002;76:5n56.
19.
Ghorbani AVaredi MHadjzadeh MAOmrani GH. Type-1 diabetes induces depot-specific alterations in adipocyte diameter and mass of adipose tissues in the ratExp Clin Endocrinol Diabetes2010118442-448Abstract. 19. Ghorbani A, Varedi M, Hadjzadeh MA, Omrani GH: Type-1 diabetes induces depot-specific alterations in adipocyte diameter and mass of adipose tissues in the rat. Exp Clin Endocrinol Diabetes 2010;118:442–448. Abstract.
20.
Jacob ANAdams-Huet BRaskin P. The visceral and subcutaneous fat changes in type 1 diabetes: a pilot studyDiabetes Obes Metab20068524-530. 20. Jacob AN, Adams-Huet B, Raskin P: The visceral and subcutaneous fat changes in type 1 diabetes: a pilot study. Diabetes Obes Metab 2006;8:524–530.
21.
Schmidt MIWatson RLDuncan BBMetcalf PBrancati FLSharrett AR et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study InvestigatorsMetabolism199645699-706. 21. Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, Sharrett AR, et al.: Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism 1996;45:699–706.
22.
Abedin MTintut YDemer L. Vascular calcification: mechanisms and clinical ramificationsArterioscler Thromb Vasc Biol2004241161-1170. 22. Abedin M, Tintut Y, Demer L: Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004;24:1161–1170.
23.
Kennedy JShavelle RWang SBudoff MDetrano R. Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiographyAm Heart J1998135696-702. 23. Kennedy J, Shavelle R, Wang S, Budoff M, Detrano R: Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiography. Am Heart J 1998;135:696–702.
24.
Conway BMiller RGCostacou TFried LKelsey SEvans RW et al. Double-edged relationship between adiposity and coronary artery calcification in type 1 diabetesDiab Vasc Dis Res20074332-339. 24. Conway B, Miller RG, Costacou T, Fried L, Kelsey S, Evans RW, et al.: Double-edged relationship between adiposity and coronary artery calcification in type 1 diabetes. Diab Vasc Dis Res 2007;4:332–339.
25.
Castiglia PT. Protein-energy malnutrition (kwashiorkor and marasmus)J Pediatr Health Care19961028-30. 25. Castiglia PT: Protein-energy malnutrition (kwashiorkor and marasmus). J Pediatr Health Care 1996;10:28–30.
26.
Watford M. Small amounts of dietary fructose dramatically increase hepatic glucose uptake through a novel mechanism of glucokinase activationNutr Rev200260253-257. 26. Watford M: Small amounts of dietary fructose dramatically increase hepatic glucose uptake through a novel mechanism of glucokinase activation. Nutr Rev 2002;60:253–257.
27.
Grodsky GMBatts AABennett LLVcella CMcwilliams NBSmith DF et al. Effect of carbohydrates on secretion of insulin from isolated rat pancreasAm J Physiol1963205638-644Abstract. 27. Grodsky GM, Batts AA, Bennett LL, Vcella C, Mcwilliams NB, Smith DF, et al.: Effect of carbohydrates on secretion of insulin from isolated rat pancreas. Am J Physiol 1963;205:638–644. Abstract.
28.
Mayes PA. Intermediary metabolism of fructoseAm J Clin Nutr1993585 Suppl754S-765S. 28. Mayes PA: Intermediary metabolism of fructose. Am J Clin Nutr 1993;58(5 Suppl):754S–765S.
29.
Busserolles JGueux ERock EMazur ARayssiguier Y. Substituting honey for refined carbohydrates protects rats from hypertriglyceridemic and prooxidative effects of fructoseJ Nutr20021323379-3382. 29. Busserolles J, Gueux E, Rock E, Mazur A, Rayssiguier Y: Substituting honey for refined carbohydrates protects rats from hypertriglyceridemic and prooxidative effects of fructose. J Nutr 2002;132:3379–3382.
30.
Najafian MEbrahim-Habibi AYaghmaei PParivar KLarijani B. Core structure of flavonoids precursor as an antihyperglycemic and antihyperlipidemic agent: an in vivo study in ratsActa Biochim Pol201057553-560. 30. Najafian M, Ebrahim-Habibi A, Yaghmaei P, Parivar K, Larijani B: Core structure of flavonoids precursor as an antihyperglycemic and antihyperlipidemic agent: an in vivo study in rats. Acta Biochim Pol 2010;57:553–560.
31.
Kim JSKwon CSSon KH. Inhibition of α-glucosidase and amylase by luteolin, a flavonoidBiosci Biotechnol Biochem2000642458-2461. 31. Kim JS, Kwon CS, Son KH: Inhibition of α-glucosidase and amylase by luteolin, a flavonoid. Biosci Biotechnol Biochem 2000;64:2458–2461.
32.
Tadera KMinami YTakamatsu KMatsuoka T. Inhibition of α-glucosidase and α-amylase by flavonoidsJ Nutr Sci Vitaminol (Tokyo)200652149-153. 32. Tadera K, Minami Y, Takamatsu K, Matsuoka T: Inhibition of α-glucosidase and α-amylase by flavonoids. J Nutr Sci Vitaminol (Tokyo) 2006;52:149–153.
33.
Lo Piparo EScheib HFrei NWilliamson GGrigorov MChou CJ et al. Flavonoids for controlling starch digestion: structural requirements for inhibiting human α-amylaseJ Med Chem2008513555-3561. 33. Lo Piparo E, Scheib H, Frei N, Williamson G, Grigorov M, Chou CJ, et al.: Flavonoids for controlling starch digestion: structural requirements for inhibiting human α-amylase. J Med Chem 2008;51:3555–3561.
34.
Aslan MOrhan DDOrhan NSezik EYesilada E. A study of antidiabetic and antioxidant effects of Helichrysum graveolens capitulums in streptozotocin-induced diabetic ratsJ Med Food200710396-400Abstract. 34. Aslan M, Orhan DD, Orhan N, Sezik E, Yesilada E: A study of antidiabetic and antioxidant effects of Helichrysum graveolens capitulums in streptozotocin-induced diabetic rats. J Med Food 2007;10:396–400. Abstract.
35.
Li WDai RJYu YHLi LWu CMLuan WWMeng WW et al. Antihyperglycaemic effect of Cephalotaxus sinensis leaves and GLUT-4 translocation facilitating activity of its flavonoid constituentsBiol Pharm Bull2007301123-1129. 35. Li W, Dai RJ, Yu YH, Li L, Wu CM, Luan WW, Meng WW, et al.: Antihyperglycaemic effect of Cephalotaxus sinensis leaves and GLUT-4 translocation facilitating activity of its flavonoid constituents. Biol Pharm Bull 2007;30:1123–1129.
36.
Sharma BBalomajumder CRoy P. Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic ratsFood Chem Toxicol2008462376-2383. 36. Sharma B, Balomajumder C, Roy P: Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic rats. Food Chem Toxicol 2008;46:2376–2383.
37.
Petrus KSchwartz HSontag G. Analysis of flavonoids in honey by HPLC coupled with coulometric electrode array detection and electrospray ionization mass spectrometryAnal Bioanal Chem20114002555-2563. 37. Petrus K, Schwartz H, Sontag G: Analysis of flavonoids in honey by HPLC coupled with coulometric electrode array detection and electrospray ionization mass spectrometry. Anal Bioanal Chem 2011;400:2555–2563.
38.
Anderson RACheng NBryden NAPolansky MMCheng NChi J et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetesDiabetes1997461786-1791Abstract. 38. Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, et al.: Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997;46:1786–1791. Abstract.
39.
Polonsky KSRubenstein AH. C-peptide as a measure of the secretion, hepatic extraction of insulin: pitfalls and limitationsDiabetes198433486-494Abstract 39. Polonsky KS, Rubenstein AH. C-peptide as a measure of the secretion and hepatic extraction of insulin: pitfalls and limitations. Diabetes 1984;33:486–494. Abstract
40.
Sjöberg SGunnarsson RGjötterberg MLefvert AKPersson AOstman J. Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitusDiabetologia198730208-213Abstract. 40. Sjöberg S, Gunnarsson R, Gjötterberg M, Lefvert AK, Persson A, Ostman J: Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987;30:208–213. Abstract.
41.
Zerbini GMangili R. LuziL: Higher post-absorptive C-peptide levels in Type 1 diabetic patients without renal complicationsDiabet Med1999161048. 41. Zerbini G, Mangili R, LuziL: Higher post-absorptive C-peptide levels in Type 1 diabetic patients without renal complications. Diabet Med 1999;16:1048.
42.
Panero FNovelli GZucco CFornengo PPerotto MSegre O et al. Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patientsDiabetes Care200932301-305. 42. Panero F, Novelli G, Zucco C, Fornengo P, Perotto M, Segre O, et al.: Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients. Diabetes Care 2009;32:301–305.
43.
Bonnefont-Rousselot DBastard JPJaudon MCDelattre J. Consequences of the diabetic status on the oxidant/antioxidant balanceDiabetes Metab200026163-176. 43. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J: Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 2000;26:163–176.
44.
Frankel SRobinson GBerenbaum M. Antioxidant capacity and correlated characteristics of 14 unifloral honeysJ Apic Res19983727-31. 44. Frankel S, Robinson G, Berenbaum M: Antioxidant capacity and correlated characteristics of 14 unifloral honeys. J Apic Res 1998;37:27–31.
45.
Gheldof NEngeseth N. Antioxidant capacity of honeys from various floral sources based on the determination of oxygen radical absorbance capacity and inhibition of in vitro lipoprotein oxidation in human serum samplesJ Agric Food Chem2002503050-3055. 45. Gheldof N, Engeseth N: Antioxidant capacity of honeys from various floral sources based on the determination of oxygen radical absorbance capacity and inhibition of in vitro lipoprotein oxidation in human serum samples. J Agric Food Chem 2002;50:3050–3055.
46.
Al Waili NBoni N. Natural honey lowers plasma prostaglandin concentrations in normal individualsJ Med Food20036129-133. 46. Al Waili N, Boni N: Natural honey lowers plasma prostaglandin concentrations in normal individuals. J Med Food 2003;6:129–133.
47.
Zeina BOthman OAl-Assad S. Effect of honey versus thyme on Rubella virus survival in vitroJ Altern Complement Med19962345-348. 47. Zeina B, Othman O, Al-Assad S: Effect of honey versus thyme on Rubella virus survival in vitro. J Altern Complement Med 1996;2:345–348.
48.
Olofsson TCVásquez A. Detection and identification of a novel lactic acid bacterial flora within the honey stomach of the honeybee Apis melliferaCurr Microbiol200857356-363. 48. Olofsson TC, Vásquez A: Detection and identification of a novel lactic acid bacterial flora within the honey stomach of the honeybee Apis mellifera. Curr Microbiol 2008;57:356–363.
Information & Authors
Information
Published In
Copyright
Copyright 2013, Mary Ann Liebert, Inc. and Korean Society of Food Science and Nutrition.
History
Published online: 8 January 2013
Published in print: January 2013
Published ahead of print: 20 December 2012
Accepted: 8 July 2012
Received: 7 April 2012
Topics
Authors
Author Disclosure Statement
All authors declare no support from any organization for the submitted work, no financial relationships with any organizations that might have an interest in the submitted work, and no other relationships or activities that could appear to have influenced the submitted work.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.